LYNDSEY WHITAKER: Open Payments
NPI 1295292332 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 64 payments from 12 companies in 2025. Trend: 2023 $18 · 2024 $1,025 · 2025 $1,581
Food & beverage: $1,481Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $357 |
| GENZYME CORPORATION | 8 | $299 |
| Janssen Biotech, Inc. | 7 | $282 |
| Lilly USA, LLC | 12 | $209 |
| LEO Pharma Inc. | 8 | $176 |
| Novartis Pharmaceuticals Corporation | 1 | $83 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
| Amgen Inc. | 2 | $42 |
| UCB, Inc. | 2 | $36 |
| Biofrontera Inc. | 1 | $21 |
Products named: DUPIXENT, TREMFYA, TALTZ, SKYRIZI, RINVOQ, ADBRY, ANZUPGO, Rhapsido.
Industry payments across AR — which companies pay providers there.
